Minimally Invasive Treatment Methods for Pilonidal Disease

Uşak University

Status: Completed

Conditions: Pilonidal Sinus

Treatments: Procedure: crystallised phenol; Procedure: Platelet rich plasma

Study type: Interventional

Funder types: Other

Identifiers

NCT03070028

PS001

Details and patient eligibility

About

Patients with pilonidal sinus disease will be randomised to two groups (crystallised phenol and platelet rich plasma). Sinus healing time, patient satisfaction, complications and recurrence rates will be compared.

Full description

Patients with pilonidal sinus disease will be treated by either crystallised phenol or platelet rich plasma application. Treatment results, healing time, postprocedural complications, patient satisfaction and recurrences will be compared.

Enrollment: 200 patients

Sex: All

Ages: 18+ years old

Volunteers: No Healthy Volunteers

Inclusion criteria

• Having pilonidal sinus disease
• accepting to be involved in the study

Exclusion criteria

• below the age of 18
• having connective tissue disorders
• diabetes mellitus
• severe anemia

Trial design

Primary purpose: Treatment

Allocation: Randomized

Interventional model: Parallel Assignment

Masking: Single Blind

---

200 participants in 2 patient groups

Phenol

Experimental group

Description:

crystallised phenol application

Treatment:

Procedure: crystallised phenol

platelet rich plasma

Experimental group

Description:

PRP application

Treatment:

Procedure: Platelet rich plasma